TrialThe New England journal of medicine2017
Tezacaftor-Ivacaftor in Residual-Function Heterozygotes with Cystic Fibrosis.
Steven M Rowe et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
232 papers cite itlatest 60 shown
this paperpooled ittrialcites it